Diabetes
402 articles
Study Shows Fungi Boost Pancreatic Cancer Development and Growth
Drs. George Miller and Berk Aykut are leading research into the role of fungi in the growth and development of pancreatic cancer.
The Link Between Depression and Pancreatic Cancer
Drs. Annette Stanton and Michael Irwin outline the links between depression and pancreatic cancer, both as a symptom of the disease and post-diagnosis.
Targeting Cancer Metabolism
Researchers from Tyme Technologies are focusing on cancer cell metabolism, particularly tyrosine, as a way to kill cancer cells.
Amazing Things—Dr. Allyson Ocean
Dr. Allyson Ocean is known for her warmth, and in a promotional video for NewYork-Presbyterian, former patient Corrine Cole explains why.
LET’S WIN! PANCREATIC CANCER Turns 5!
Let’s Win has reached its 5th anniversary. Read about our development and what we have accomplished in 5 short years.
Oncologists Are Struggling to Treat Cancer Patients Amid the Pandemic
Dr. Allyson Ocean explains the changes to her practice and risks she and her patients face as they battle cancer amid the COVID-19 pandemic.
A Platinum Remembrance: The Power of Raising Your Voice
Gil Bashe and John Bianchi share a remembrance of Anne Glauber’s work and the power of advocacy on the eve of the Platinum PR Awards.
Let’s Win! Pancreatic Cancer Updates Clinical Trials Section
Let’s Win announces updates to its clinical trials section on its website. These include a new clinical trial finder, animations,and educational pages.
Let’s Win Pancreatic Cancer: Leading the Way Forward for Patients
The Biden Cancer Initiative has launched Pulse on Progress, an online magazine on Medium, and Let’s Win is featured in the first edition. The article focuses on how Let’s Win is changing the narrative around pancreatic cancer.
Adjuvant Chemotherapy with Modified FOLFIRINOX Regimen Improves Survival
A French clinical trial showed that adjuvant chemotherapy (given after surgery) with modified FOLFIRINOX improves survival of pancreatic cancer patients.
Testing a Drug that Works Only in the Tumor Microenvironment
Scientists are trying a new type of drug combination that gets activated only in the unique conditions of the tumor microenvironment.
